Program Moderator: Dr. Timo Nazari-Shafti, BCRT & DHZC
Registration & Welcome Coffee
|09:00 a.m.||Welcome Address|
Dr. Timo Nazari-Shafti, BIH Center for Regenerative Therapies (BCRT) & Deutsches Herzzentrum der Charité (DHZC)
Prof. Christopher Baum, BIH at Charité (online)
Dr. Jasmin Podufall, Berlin Partner & HealthCapital
|Scientific Input and Discussion|
Prof. Atta Behfar, Mayo Clinic (online)
Lead question:How can patients shape novel therapy developments? (vision or use-cases)
|Peter Böhm, Patient representative (Field: rheumatology)|
Franziska Bleis, Patient (Field: cardio)
Requirements for inclusive ATMP development for common diseases
|Break-Out Sessions – four passes in rotation (20 min per round)|
||Introduction World Coffee (Dr. Timo Nazari-Shafti, BCRT & DHZC)|
|World Café “Patients” (Dr. Felix Fischer, Charité)|
Lead questions:How can PROMs be brought into greater use?
How can we better represent different patient views.
How can we integrate the patient perspective more strongly in the conduct of clinical trials?
|World Café “Regulatory Affairs” (Dr. Christoph Conrad, BIH at Charité)|
Lead questions:Which regulatory aspects could strengthen and further the innovative potential in Germany? How to de-risk ATMP clinical trials from a regulatory perspective? How to better interact with regulatory instances?
World Café “Industry” (Joachim von Arnim, Cellbricks)
Which models and structures are necessary for a multi-lateral co-creation? Which strategic developments / infrastructures are needed for a hub of ATMPs from industry perspective? What are current barriers for investing in ATMP developments?
|World Café “Clinical” (Dr. Timo Nazari-Shafti, BCRT & DHZC)|
Lead questions:How would an optimal hub for ATMP development look like? Which are barriers for ATMP developments? What can we learn from other hub-like structures?
|02:15 p.m.||Results Breakouts:|
World Coffee "Patients"
World Coffee "Regulatory Affairs"
World Coffee "Industry"
World Coffee "Clinical"
||Wrap up & Networking Coffee (Dr. Timo Nazari-Shafti, BCRT & DHZC; all)
|04:00 p.m.||End of Conference|